Determinants of long-term response to group therapy for dysfunctional fear of progression in chronic diseases.

Behav Med

Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technische Unversität München, München, Germany.

Published: January 2012

Prior work demonstrated that cognitive-behavioral (CBT) and supportive-experiential (SET) group interventions can reduce dysfunctional fear of progression (FoP) in patients with chronic diseases. In this secondary analysis of a randomized controlled study, we investigated determinants of long-term response to group therapy for FoP. Response to therapy after 12 months was assessed using the Reliable Change Index (RCI). Outcome data were available for 129 patients with cancer and 116 patients with chronic arthritis. 37.9% of the patients in the CBT group and 32.7% of those attending the SET group indicated response to therapy (p=.402). Educational level predicted long-term response to therapy (OR 2.53, 95% CI 1.33-4.81; p=.005). Medical patients with lower education may need additional attention in order to gain long-lasting benefit from brief group psychotherapy. However, this investigation needs to be replicated in a study that includes a broader range of psychological predictors.

Download full-text PDF

Source
http://dx.doi.org/10.1080/08964289.2011.640364DOI Listing

Publication Analysis

Top Keywords

long-term response
12
response therapy
12
determinants long-term
8
response group
8
group therapy
8
dysfunctional fear
8
fear progression
8
chronic diseases
8
set group
8
patients chronic
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!